IL89118A0 - Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1 - Google Patents
Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1Info
- Publication number
- IL89118A0 IL89118A0 IL89118A IL8911889A IL89118A0 IL 89118 A0 IL89118 A0 IL 89118A0 IL 89118 A IL89118 A IL 89118A IL 8911889 A IL8911889 A IL 8911889A IL 89118 A0 IL89118 A0 IL 89118A0
- Authority
- IL
- Israel
- Prior art keywords
- immunodeficiency virus
- human immunodeficiency
- virus type
- vaccine containing
- polypeptides derived
- Prior art date
Links
- 241000713772 Human immunodeficiency virus 1 Species 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15197688A | 1988-02-03 | 1988-02-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL89118A0 true IL89118A0 (en) | 1989-08-15 |
Family
ID=22541066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL89118A IL89118A0 (en) | 1988-02-03 | 1989-01-30 | Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0327180A3 (de) |
JP (1) | JPH02203793A (de) |
KR (1) | KR890013176A (de) |
AU (1) | AU2520692A (de) |
BR (1) | BR8900515A (de) |
IL (1) | IL89118A0 (de) |
LT (1) | LTIP1795A (de) |
ZA (1) | ZA89862B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL102092A (en) * | 1991-06-11 | 1996-11-14 | Microgenesys Inc | Use of recombinant VIH protein wrapped in VIH abduction drug and a pharmaceutical preparation containing the accumulated protein |
DE4228787A1 (de) | 1992-08-29 | 1994-03-03 | Chemotherapeutisches Forschungsinstitut Georg Speyer Haus | Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate |
WO1994028929A1 (en) | 1993-06-07 | 1994-12-22 | Genentech, Inc. | Hiv envelope polypeptides |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
US5917502A (en) * | 1995-12-06 | 1999-06-29 | Intergraph Corporation | Peer-to-peer parallel processing graphics accelerator |
US6585979B1 (en) | 1996-07-08 | 2003-07-01 | Genentech, Inc. | HIV envelope polypeptides and immunogenic composition |
ZA975889B (en) * | 1996-07-08 | 1998-02-23 | Genentech Inc | HIV envelope polypeptides and vaccine. |
US6017537A (en) * | 1998-12-18 | 2000-01-25 | Connaught Laboratories, Inc. | Formyl methionyl peptide vaccine adjuvant |
DE19907485B4 (de) * | 1999-02-12 | 2008-01-17 | Strathmann Ag & Co. | Virus-Vakzine |
US7786288B2 (en) * | 2003-10-23 | 2010-08-31 | Karp Nelson M | Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61233700A (ja) * | 1984-12-24 | 1986-10-17 | ジエネンテク,インコ−ポレイテツド | 分子クロ−ンされたエイズ関連ポリペプチド |
NZ217645A (en) * | 1985-09-25 | 1991-11-26 | Oncogen | Recombinant viruses expressing lav/htlv-iii related epitopes and vaccine formulations |
EP0238893B1 (de) * | 1986-03-20 | 1992-10-28 | Abbott Laboratories | Rekombinante Parvovirus-RA-1-Produkte und Verfahren zu deren Anwendung |
IL82104A0 (en) * | 1986-04-08 | 1987-10-30 | Usa | Recombinant vaccinia virus expressing human retrovirus genes and method for producing htlb-iii envelope proteins |
IE872748L (en) * | 1986-10-16 | 1988-04-16 | Arjomari Europ | Polypeptides derived from the evvelope gene of human¹immunodeficiency virus in recombinant baculovirus infected¹insect cells |
-
1989
- 1989-01-30 IL IL89118A patent/IL89118A0/xx unknown
- 1989-02-02 EP EP89200230A patent/EP0327180A3/de not_active Withdrawn
- 1989-02-02 KR KR1019890001191A patent/KR890013176A/ko not_active Application Discontinuation
- 1989-02-03 BR BR898900515A patent/BR8900515A/pt not_active Application Discontinuation
- 1989-02-03 ZA ZA89862A patent/ZA89862B/xx unknown
- 1989-02-03 JP JP1027337A patent/JPH02203793A/ja active Pending
-
1992
- 1992-09-18 AU AU25206/92A patent/AU2520692A/en not_active Abandoned
-
1994
- 1994-01-24 LT LTIP1795A patent/LTIP1795A/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR890013176A (ko) | 1989-09-21 |
EP0327180A2 (de) | 1989-08-09 |
AU632039B2 (en) | 1992-12-17 |
BR8900515A (pt) | 1989-10-03 |
EP0327180A3 (de) | 1990-07-18 |
LTIP1795A (en) | 1995-08-25 |
JPH02203793A (ja) | 1990-08-13 |
AU2955789A (en) | 1989-08-03 |
AU2520692A (en) | 1992-12-17 |
ZA89862B (en) | 1989-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR241940A1 (es) | Metodo para construir un vector de expresion recombinante de virus de polihedrosis nuclear de autographa californica, sintesis y purificiacion. | |
JPS6425800A (en) | T-cell epitope of hepatities b virus nucleocapside protein | |
NO882075D0 (no) | 9-alfa-hydroksysteroider, deres fremstilling, en fremgangsmaate for fremstilling av de tilsvarende 9(11)-dehydro-derivater samt farmasoeytiske preparater inneholdend | |
NZ205341A (en) | 37 residue influenza virus peptide and vaccines | |
NZ220365A (en) | Antiviral peptides and pharmaceutical compositions | |
AU1255383A (en) | Foot and mouth disease viral antigenic peptides | |
NZ219909A (en) | Recombinant vaccinia virus expressing human (hiv) retrovirus gene | |
GB8821528D0 (en) | Recombinant vaccinia virus | |
EP0631506A4 (de) | Impstoffe die das deglykosytierte hüllprotein des humanen immunschwäche virus vom typ 1 enthalten. | |
EP0491844A4 (en) | Peptides including ctl epitopes of hiv proteins and use thereof | |
IL89118A0 (en) | Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1 | |
IL85885A0 (en) | Cyclic peptides,their preparation and pharmaceutical compositions containing them | |
GB8809228D0 (en) | Novel peptides their preparation & use | |
AU3557889A (en) | Protective peptides derived from human immunodeficiency virus-1 gp160 | |
NZ224393A (en) | Recombinant hiv envelope proteins and uses thereof | |
AU632039C (en) | Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1 | |
GB8619182D0 (en) | Peptides & derivatives | |
GB2193206B (en) | Preparation of taurine-containing peptides | |
ZA883878B (en) | Human immunodeficiency virus gag-encoded proteins | |
AU2715288A (en) | Human respiratory syncytialvirus vaccine derived from the 1a (9.5 kd) protein | |
IL82780A0 (en) | Peptides,their manufacture and pharmaceutical compositions containing them | |
GB2273709B (en) | Peptide fragments of HIV | |
IE881635L (en) | Human immunodeficiency virus gag-encoded proteins | |
KR970009290B1 (en) | Recombinant dna and expression plasmid for the preparation of motilin-like peptide | |
IE862908L (en) | Aids virus gene expression |